RaySearch Laboratories AB (publ) announces that Oregon Health & Science University (OHSU) in the USA has placed an order for the treatment planning system RayStation®*.
OHSU has purchased RayStation for treatment planning which will be used with the Radixact system from Accuray. The center intends to implement adaptive therapy to acquire daily patient images and perform treatment adaptations such that the patient's treatment is optimized. OHSU and RaySearch consider this approach to precision medicine to be the future of radiation therapy.
Dr. John Bayouth, Vice Chair, Director of Physics and Chief Medical Physicist at OHSU says: “OHSU is building the organization’s technological platforms for advanced radiation therapy. We are pleased to collaborate with industry leaders like RaySearch to help bring precision medicine from research to clinical use. Adaptive therapy is the next obvious step toward delivering the right treatment every day for every patient. We are encouraged to be at the forefront of implementing these hardware and software innovations to improve patient care.”
Johan Löf, founder and CEO, RaySearch, says: “I am greatly encouraged that OHSU will integrate RayStation with Radixact, marking another step forward in our commitment to advancing radiation technology. This collaboration broadens the availability of our innovative solutions, ultimately enhancing the quality of care for cancer patients.”
The order was received and delivered in Q3, 2023.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00